‘GLIMET’ vs ‘ELGIMET’: Bombay High Court flags risk of confusion in diabetes drugs

📅 Published: November 19, 2025 | 📂 Category: Uncategorized

The Bombay High Court says that slightest probability of confusion in medicinal products warrants restraint

📱 Share on WhatsApp

Leave a Reply

Your email address will not be published. Required fields are marked *